Enzymes for β-lactam Antibiotics - Global Top Players Market Share and Ranking 2026- YH Research

Home > Reports >Pharma & Healthcare > Enzymes for β-lactam Antibiotics - Global Top Players Market Share and Ranking 2026

Enzymes for β-lactam Antibiotics - Global Top Players Market Share and Ranking 2026

Publication Date: 2026-07-09
Report Id: 2894736
Industry: Pharma & Healthcare
Report Page: 123
Chart: 130

PDF Download

Publication Date: 2026-07-09
Report Id: 2894736
Industry: Pharma & Healthcare
Report Page: 123
Chart: 130

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Enzymes for β-lactam Antibiotics Definition
1.2 Global Enzymes for β-lactam Antibiotics Market Size and Forecast
1.2.1 By Consumption Value, Global Enzymes for β-lactam Antibiotics Market Size, 2021-2032
1.2.2 By Sales Quantity, Global Enzymes for β-lactam Antibiotics Market Size, 2021-2032
1.2.3 Global Enzymes for β-lactam Antibiotics Average Selling Price (ASP), 2021-2032
1.3 Japan Enzymes for β-lactam Antibiotics Market Size and Forecast
1.3.1 By Consumption Value, Japan Enzymes for β-lactam Antibiotics Market Size, 2021-2032
1.3.2 By Sales Quantity, Japan Enzymes for β-lactam Antibiotics Market Size, 2021-2032
1.3.3 Japan Enzymes for β-lactam Antibiotics Average Selling Price (ASP), 2021-2032
1.4 Share of Japan Enzymes for β-lactam Antibiotics Market with Respect to the Global Market
1.4.1 By Consumption Value, Japan Enzymes for β-lactam Antibiotics Market Share in Global, 2021-2032
1.4.2 By Sales Quantity, Japan Enzymes for β-lactam Antibiotics Market Share in Global, 2021-2032
1.4.3 Enzymes for β-lactam Antibiotics Market Size: Japan VS Global, 2021-2032
1.5 Enzymes for β-lactam Antibiotics Market Dynamics
1.5.1 Enzymes for β-lactam Antibiotics Market Drivers
1.5.2 Enzymes for β-lactam Antibiotics Market Restraints
1.5.3 Enzymes for β-lactam Antibiotics Industry Trends
1.5.4 Enzymes for β-lactam Antibiotics Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Enzymes for β-lactam Antibiotics, Global Market Share by Company, 2021-2026
2.2 By Sales Quantity of Enzymes for β-lactam Antibiotics, Global Market Share by Company, 2021-2026
2.3 Enzymes for β-lactam Antibiotics Average Selling Price (ASP) by Company, 2021-2026
2.4 Global Enzymes for β-lactam Antibiotics Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Enzymes for β-lactam Antibiotics Concentration Ratio
2.6 Global Enzymes for β-lactam Antibiotics Mergers & Acquisitions, Expansion Plans
2.7 Global Enzymes for β-lactam Antibiotics Manufacturers Product Type
2.8 Head Office and Enzymes for β-lactam Antibiotics Production Site of Key Manufacturer
2.9 Enzymes for β-lactam Antibiotics Capacity of Major Manufacturers and Future Plan

3 Japan Leading Manufacturers and Market Share
3.1 By Revenue of Enzymes for β-lactam Antibiotics, Japan Market Share by Company, 2021-2026
3.2 By Sales Quantity of Enzymes for β-lactam Antibiotics, Japan Market Share by Company, 2021-2026
3.3 Japan Enzymes for β-lactam Antibiotics Enzymes for β-lactam Antibiotics Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Enzymes for β-lactam Antibiotics Capacity, Output and Capacity Utilization, 2021-2032
4.2 Global Enzymes for β-lactam Antibiotics Capacity by Region
4.3 Global Enzymes for β-lactam Antibiotics Production & Forecast by Region, 2021 VS 2025 VS 2032
4.4 Global Enzymes for β-lactam Antibiotics Production by Region, 2021-2032
4.5 Global Enzymes for β-lactam Antibiotics Production Market Share & Forecast by Region, 2021-2032

5 Industry Chain Analysis
5.1 Enzymes for β-lactam Antibiotics Industry Chain
5.2 Enzymes for β-lactam Antibiotics Upstream Analysis
5.2.1 Enzymes for β-lactam Antibiotics Core Raw Materials
5.2.2 Main Manufacturers of Enzymes for β-lactam Antibiotics Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Enzymes for β-lactam Antibiotics Production Mode
5.6 Enzymes for β-lactam Antibiotics Procurement Model
5.7 Enzymes for β-lactam Antibiotics Industry Sales Model and Sales Channels
5.7.1 Enzymes for β-lactam Antibiotics Sales Model
5.7.2 Enzymes for β-lactam Antibiotics Typical Distributors

6 Sights Enzymes for β-lactam Antibiotics Market Classification
6.1 Enzymes for β-lactam Antibiotics Classification by Type
6.1.1 β-lactamase
6.1.2 Penicillin Acylase
6.1.3 Other
6.1.4 by Type, Global Enzymes for β-lactam Antibiotics Consumption Value, 2021-2032
6.1.5 by Type, Global Enzymes for β-lactam Antibiotics Sales Quantity, 2021-2032
6.1.6 by Type, Global Enzymes for β-lactam Antibiotics Average Selling Price (ASP), 2021-2032
6.2 Enzymes for β-lactam Antibiotics Classification by Process Use
6.2.1 6-APA Route
6.2.2 7-ACA Route
6.2.3 7-ADCA Route
6.2.4 Semi-Synthetic Antibiotic Route
6.2.5 by Process Use, Global Enzymes for β-lactam Antibiotics Consumption Value, 2021-2032
6.2.6 by Process Use, Global Enzymes for β-lactam Antibiotics Sales Quantity, 2021-2032
6.2.7 by Process Use, Global Enzymes for β-lactam Antibiotics Average Selling Price (ASP), 2021-2032
6.3 Enzymes for β-lactam Antibiotics Classification by Product Form
6.3.1 Free Enzyme Type
6.3.2 Immobilized Enzyme Type
6.3.3 Recombinant Enzyme Type
6.3.4 Whole-Cell Catalyst Type
6.3.5 by Product Form, Global Enzymes for β-lactam Antibiotics Consumption Value, 2021-2032
6.3.6 by Product Form, Global Enzymes for β-lactam Antibiotics Sales Quantity, 2021-2032
6.3.7 by Product Form, Global Enzymes for β-lactam Antibiotics Average Selling Price (ASP), 2021-2032

7 Sights by Application
7.1 Enzymes for β-lactam Antibiotics Segment by Application
7.1.1 Cephalosporins
7.1.2 Penicillin and Its Derivatives
7.1.3 Monoamide Ring
7.1.4 Other
7.2 by Application, Global Enzymes for β-lactam Antibiotics Consumption Value & CAGR, 2021 VS 2025 VS 2032
7.3 by Application, Global Enzymes for β-lactam Antibiotics Consumption Value, 2021-2032
7.4 by Application, Global Enzymes for β-lactam Antibiotics Sales Quantity, 2021-2032
7.5 by Application, Global Enzymes for β-lactam Antibiotics Price, 2021-2032

8 Sales Sights by Region
8.1 By Region, Global Enzymes for β-lactam Antibiotics Consumption Value, 2021 VS 2025 VS 2032
8.2 By Region, Global Enzymes for β-lactam Antibiotics Consumption Value, 2021-2032
8.3 By Region, Global Enzymes for β-lactam Antibiotics Sales Quantity, 2021-2032
8.4 North America
8.4.1 North America Enzymes for β-lactam Antibiotics Market Size & Forecasts, 2021-2032
8.4.2 By Country, North America Enzymes for β-lactam Antibiotics Market Size Market Share
8.5 Europe
8.5.1 Europe Enzymes for β-lactam Antibiotics Market Size & Forecasts, 2021-2032
8.5.2 By Country, Europe Enzymes for β-lactam Antibiotics Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Enzymes for β-lactam Antibiotics Market Size & Forecasts, 2021-2032
8.6.2 By Country/Region, Asia Pacific Enzymes for β-lactam Antibiotics Market Size Market Share
8.7 South America
8.7.1 South America Enzymes for β-lactam Antibiotics Market Size & Forecasts, 2021-2032
8.7.2 By Country, South America Enzymes for β-lactam Antibiotics Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Enzymes for β-lactam Antibiotics Market Size & CAGR, 2021 VS 2025 VS 2032
9.2 By Country, Global Enzymes for β-lactam Antibiotics Consumption Value, 2021-2032
9.3 By Country, Global Enzymes for β-lactam Antibiotics Sales Quantity, 2021-2032
9.4 United States
9.4.1 United States Enzymes for β-lactam Antibiotics Market Size, 2021-2032
9.4.2 by Type, United States Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.4.3 by Application, United States Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.5 Europe
9.5.1 Europe Enzymes for β-lactam Antibiotics Market Size, 2021-2032
9.5.2 by Type, Europe Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.5.3 by Application, Europe Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.6 China
9.6.1 China Enzymes for β-lactam Antibiotics Market Size, 2021-2032
9.6.2 by Type, China Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.6.3 by Application, China Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.7 Japan
9.7.1 Japan Enzymes for β-lactam Antibiotics Market Size, 2021-2032
9.7.2 by Type, Japan Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.7.3 by Application, Japan Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.8 South Korea
9.8.1 South Korea Enzymes for β-lactam Antibiotics Market Size, 2021-2032
9.8.2 by Type, South Korea Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.8.3 by Application, South Korea Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.9 Southeast Asia
9.9.1 Southeast Asia Enzymes for β-lactam Antibiotics Market Size, 2021-2032
9.9.2 by Type, Southeast Asia Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.9.3 by Application, Southeast Asia Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.10 India
9.10.1 India Enzymes for β-lactam Antibiotics Market Size, 2021-2032
9.10.2 by Type, India Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.10.3 by Application, India Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.11 Middle East & Africa
9.11.1 Middle East & Africa Enzymes for β-lactam Antibiotics Market Size, 2021-2032
9.11.2 by Type, Middle East & Africa Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032
9.11.3 by Application, Middle East & Africa Enzymes for β-lactam Antibiotics Sales Quantity Market Share, 2025 VS 2032

10 Manufacturers Profile
10.1 Novozymes / Novonesis
10.1.1 Novozymes / Novonesis Company Information, Head Office, Market Area, and Industry Position
10.1.2 Novozymes / Novonesis Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.1.3 Novozymes / Novonesis Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.1.4 Novozymes / Novonesis Company Profile and Main Business
10.1.5 Novozymes / Novonesis Recent Developments
10.2 DSM / dsm-firmenich
10.2.1 DSM / dsm-firmenich Company Information, Head Office, Market Area, and Industry Position
10.2.2 DSM / dsm-firmenich Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.2.3 DSM / dsm-firmenich Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.2.4 DSM / dsm-firmenich Company Profile and Main Business
10.2.5 DSM / dsm-firmenich Recent Developments
10.3 Amano Enzyme
10.3.1 Amano Enzyme Company Information, Head Office, Market Area, and Industry Position
10.3.2 Amano Enzyme Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.3.3 Amano Enzyme Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.3.4 Amano Enzyme Company Profile and Main Business
10.3.5 Amano Enzyme Recent Developments
10.4 Fermenta Biotech
10.4.1 Fermenta Biotech Company Information, Head Office, Market Area, and Industry Position
10.4.2 Fermenta Biotech Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.4.3 Fermenta Biotech Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.4.4 Fermenta Biotech Company Profile and Main Business
10.4.5 Fermenta Biotech Recent Developments
10.5 Advanced Enzyme Technologies
10.5.1 Advanced Enzyme Technologies Company Information, Head Office, Market Area, and Industry Position
10.5.2 Advanced Enzyme Technologies Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.5.3 Advanced Enzyme Technologies Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.5.4 Advanced Enzyme Technologies Company Profile and Main Business
10.5.5 Advanced Enzyme Technologies Recent Developments
10.6 Biosynth
10.6.1 Biosynth Company Information, Head Office, Market Area, and Industry Position
10.6.2 Biosynth Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.6.3 Biosynth Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.6.4 Biosynth Company Profile and Main Business
10.6.5 Biosynth Recent Developments
10.7 Creative Enzymes
10.7.1 Creative Enzymes Company Information, Head Office, Market Area, and Industry Position
10.7.2 Creative Enzymes Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.7.3 Creative Enzymes Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.7.4 Creative Enzymes Company Profile and Main Business
10.7.5 Creative Enzymes Recent Developments
10.8 Codexis
10.8.1 Codexis Company Information, Head Office, Market Area, and Industry Position
10.8.2 Codexis Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.8.3 Codexis Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.8.4 Codexis Company Profile and Main Business
10.8.5 Codexis Recent Developments
10.9 c-LEcta / Kerry
10.9.1 c-LEcta / Kerry Company Information, Head Office, Market Area, and Industry Position
10.9.2 c-LEcta / Kerry Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.9.3 c-LEcta / Kerry Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.9.4 c-LEcta / Kerry Company Profile and Main Business
10.9.5 c-LEcta / Kerry Recent Developments
10.10 Meiji Seika Pharma
10.10.1 Meiji Seika Pharma Company Information, Head Office, Market Area, and Industry Position
10.10.2 Meiji Seika Pharma Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.10.3 Meiji Seika Pharma Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.10.4 Meiji Seika Pharma Company Profile and Main Business
10.10.5 Meiji Seika Pharma Recent Developments
10.11 Kyowa Hakko Bio
10.11.1 Kyowa Hakko Bio Company Information, Head Office, Market Area, and Industry Position
10.11.2 Kyowa Hakko Bio Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.11.3 Kyowa Hakko Bio Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.11.4 Kyowa Hakko Bio Company Profile and Main Business
10.11.5 Kyowa Hakko Bio Recent Developments
10.12 Datong Shuangyan Pharmaceutical
10.12.1 Datong Shuangyan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.12.2 Datong Shuangyan Pharmaceutical Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.12.3 Datong Shuangyan Pharmaceutical Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.12.4 Datong Shuangyan Pharmaceutical Company Profile and Main Business
10.12.5 Datong Shuangyan Pharmaceutical Recent Developments
10.13 Shanghai Enzyme
10.13.1 Shanghai Enzyme Company Information, Head Office, Market Area, and Industry Position
10.13.2 Shanghai Enzyme Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.13.3 Shanghai Enzyme Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.13.4 Shanghai Enzyme Company Profile and Main Business
10.13.5 Shanghai Enzyme Recent Developments
10.14 Hubei Merriclin Pharmaceutical
10.14.1 Hubei Merriclin Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Hubei Merriclin Pharmaceutical Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.14.3 Hubei Merriclin Pharmaceutical Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.14.4 Hubei Merriclin Pharmaceutical Company Profile and Main Business
10.14.5 Hubei Merriclin Pharmaceutical Recent Developments
10.15 Zhejiang Huahai Pharmaceutical
10.15.1 Zhejiang Huahai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.15.2 Zhejiang Huahai Pharmaceutical Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.15.3 Zhejiang Huahai Pharmaceutical Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.15.4 Zhejiang Huahai Pharmaceutical Company Profile and Main Business
10.15.5 Zhejiang Huahai Pharmaceutical Recent Developments
10.16 North China Pharmaceutical
10.16.1 North China Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.16.2 North China Pharmaceutical Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.16.3 North China Pharmaceutical Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.16.4 North China Pharmaceutical Company Profile and Main Business
10.16.5 North China Pharmaceutical Recent Developments
10.17 CSPC Pharmaceutical Group
10.17.1 CSPC Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
10.17.2 CSPC Pharmaceutical Group Enzymes for β-lactam Antibiotics Models, Specifications, and Application
10.17.3 CSPC Pharmaceutical Group Enzymes for β-lactam Antibiotics Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.17.4 CSPC Pharmaceutical Group Company Profile and Main Business
10.17.5 CSPC Pharmaceutical Group Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Enzymes for β-lactam Antibiotics should grow from US$ 170 million in 2025 to US$ 254 million by 2032, with a CAGR of 5.6% for the period of 2026-2032.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Enzymes for β-lactam Antibiotics

According to YH Research, the global market for Enzymes for β-lactam Antibiotics should grow from US$ 170 million in 2025 to US$ 254 million by 2032, with a CAGR of 5.6% for the period of 2026-2032.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Enzymes for β-lactam Antibiotics refer to industrial biocatalysts used in the production, transformation, side-chain modification, and intermediate preparation of β-lactam antibiotics, including penicillins, cephalosporins, carbapenems, and related semi-synthetic antibiotics. These enzymes are mainly used to selectively cleave or form side-chain amide bonds while preserving the β-lactam nucleus, enabling cleaner and milder manufacturing routes compared with traditional chemical processes. In this report, the market mainly includes penicillin G acylase, penicillin V acylase, cephalosporin C acylase, glutaryl acylase, D-amino acid oxidase, esterases, lipases, immobilized β-lactam acylases, recombinant enzyme catalysts, and engineered enzyme systems for β-lactam antibiotic synthesis. The 2025 benchmark ASP is US$68,000 / ton, shipment volume is 2.35k tons, and average gross margin is 48%. The upstream industry chain includes microbial strains, recombinant expression systems, fermentation media, enzyme carriers, immobilization resins, crosslinking reagents, buffers, filtration membranes, chromatography materials, and bioprocess equipment. The midstream includes strain engineering, enzyme fermentation, cell disruption, enzyme purification, immobilization, activity standardization, stability improvement, enzyme formulation, quality testing, packaging, and technical application support. The downstream includes β-lactam API manufacturers, 6-APA manufacturers, 7-ACA manufacturers, 7-ADCA producers, semi-synthetic penicillin producers, cephalosporin manufacturers, pharmaceutical CDMOs, and antibiotic intermediate producers.

Enzymes for β-lactam antibiotics are a specialized but strategically important segment of pharmaceutical biocatalysis. Their value comes from replacing harsh chemical hydrolysis and side-chain modification routes with selective enzymatic processes that can reduce solvent use, lower waste generation, improve product purity, and support greener antibiotic manufacturing. Penicillin G acylase remains the core commercial enzyme because it is widely used for producing 6-APA, while cephalosporin-related acylases and engineered enzymes are increasingly important for 7-ACA, 7-ADCA and semi-synthetic cephalosporin pathways. Immobilized enzymes dominate many industrial applications because they can be reused, separated more easily, and operated with better stability in continuous or repeated batch processes. Market growth is mainly driven by sustained demand for amoxicillin, ampicillin, cephalexin, cefadroxil and other semi-synthetic β-lactam antibiotics, as well as pressure to improve environmental performance in antibiotic API manufacturing. However, growth is moderate because β-lactam antibiotics are mature products, enzyme costs must remain compatible with low-margin API economics, and some manufacturers already operate highly optimized in-house enzyme systems. Future development will focus on higher enzyme activity, better thermal and pH stability, lower product inhibition, improved immobilization carriers, recombinant enzyme production, direct one-step conversion of cephalosporin C to 7-ACA, and customized biocatalysts for greener semi-synthetic antibiotic routes.

This report studies and analyses global Enzymes for β-lactam Antibiotics status and future trends, helps the client to determine the Enzymes for β-lactam Antibiotics market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Enzymes for β-lactam Antibiotics, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Enzymes for β-lactam Antibiotics market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (Tons)
(2) Global Enzymes for β-lactam Antibiotics sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (Tons)
(3) Japan Enzymes for β-lactam Antibiotics sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (Tons)
(4) Global Enzymes for β-lactam Antibiotics key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Enzymes for β-lactam Antibiotics key producing regions, capacity, production, and year over year growth
(6) Enzymes for β-lactam Antibiotics industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Novozymes / Novonesis
    DSM / dsm-firmenich
    Amano Enzyme
    Fermenta Biotech
    Advanced Enzyme Technologies
    Biosynth
    Creative Enzymes
    Codexis
    c-LEcta / Kerry
    Meiji Seika Pharma
    Kyowa Hakko Bio
    Datong Shuangyan Pharmaceutical
    Shanghai Enzyme
    Hubei Merriclin Pharmaceutical
    Zhejiang Huahai Pharmaceutical
    North China Pharmaceutical
    CSPC Pharmaceutical Group

Market segment by Type, covers
    β-lactamase
    Penicillin Acylase
    Other

Market segment by Process Use, covers
    6-APA Route
    7-ACA Route
    7-ADCA Route
    Semi-Synthetic Antibiotic Route

Market segment by Product Form, covers
    Free Enzyme Type
    Immobilized Enzyme Type
    Recombinant Enzyme Type
    Whole-Cell Catalyst Type

Market segment by Application, can be divided into
    Cephalosporins
    Penicillin and Its Derivatives
    Monoamide Ring
    Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Enzymes for β-lactam Antibiotics product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Enzymes for β-lactam Antibiotics market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Enzymes for β-lactam Antibiotics market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Enzymes for β-lactam Antibiotics, percent & CAGR, 2021-2032
Chapter 5: Enzymes for β-lactam Antibiotics industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions